<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><feed xmlns='http://www.w3.org/2005/Atom' xmlns:openSearch='http://a9.com/-/spec/opensearchrss/1.0/' xmlns:georss='http://www.georss.org/georss' xmlns:gd='http://schemas.google.com/g/2005' xmlns:thr='http://purl.org/syndication/thread/1.0'><id>tag:blogger.com,1999:blog-11762243</id><updated>2011-04-21T15:01:06.282-07:00</updated><title type='text'>JOIN A MS TRIAL AT BARROW</title><subtitle type='html'></subtitle><link rel='http://schemas.google.com/g/2005#feed' type='application/atom+xml' href='http://ms-treatments-research.blogspot.com/feeds/posts/default'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/11762243/posts/default?max-results=100'/><link rel='alternate' type='text/html' href='http://ms-treatments-research.blogspot.com/'/><link rel='hub' href='http://pubsubhubbub.appspot.com/'/><author><name>MSnewsChanel.com.com</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><generator version='7.00' uri='http://www.blogger.com'>Blogger</generator><openSearch:totalResults>1</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>100</openSearch:itemsPerPage><entry><id>tag:blogger.com,1999:blog-11762243.post-111243317840299485</id><published>2005-07-08T01:08:00.000-07:00</published><updated>2005-10-25T14:29:03.393-07:00</updated><title type='text'>CALL BARROW NEUROLOGICAL INSTITUTE AT 602-406-7711 TO ENROLL IN ANY OF THE 14 TRIALS BELOW</title><content type='html'>Please leave a message with your contact information. Lou DiCave, Colleen Sweeney, Krya Perry or Carrie Jones will call you with information on the trials currently being conducted and help you enroll if you qualify.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; color: rgb(255, 0, 0);"&gt;(1) ZAMVIL&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;(ITN020AI) evaluate effects of Lipitor on MRI activity, this is a&lt;br /&gt;double blind placebo controlled trial, looking for pt's 18 to 50 years old&lt;br /&gt;that are NOT yet diagnosed with MS and who have had a symptom w/in the last&lt;br /&gt;48 days.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; color: rgb(51, 51, 255);"&gt;RRMS  (relapse remitting MS)ONLY studies:&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;(&lt;span style="font-weight: bold; color: rgb(255, 0, 0);"&gt;2) BERLEX&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;306440 "BEYOND" studying the effects of Betaseron at 250 and 500ug&lt;br /&gt;or copaxone (3arm trial) looking for pt's that have never taken copaxone or&lt;br /&gt;any interferons 18 to 55 years of age.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color: rgb(255, 0, 0); font-weight: bold;"&gt;(3) BNI-IMM004&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;This is one of our internal protocols studying the effects of&lt;br /&gt;combination treatment with copaxone and Lipitor vs. copaxone alone.  looking&lt;br /&gt;for 18 to 55 yrs old and never had copaxone in past&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; color: rgb(255, 0, 0);"&gt;(4) ComBiRx&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;Placebo controlled trial studying effects of combined use of&lt;br /&gt;Avonex + Copaxone, avonex + placebo, or Copaxone + placebo  looking for pt's&lt;br /&gt;18 to 60 yrs old, naive to all MS therapies.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; color: rgb(255, 0, 0);"&gt;(5) ASSERT &lt;/span&gt;&lt;br /&gt;&lt;br /&gt;Placebo controlled studying effects of copaxone + oral steroids&lt;br /&gt;or copaxone + placebo looking for pt's 18 to 50 yrs old who never had&lt;br /&gt;copaxone in past&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; color: rgb(255, 0, 0);"&gt;(6) HERMES &lt;/span&gt;&lt;br /&gt;&lt;br /&gt;u2787g placebo controlled trial studying the effects of Rituximab&lt;br /&gt;looking for 18 to 50 yrs old that have a documented relapse in the past year&lt;br /&gt;and washed off interferons and copaxone for at least 60 days&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; color: rgb(51, 51, 255);"&gt;SPMS (secondary progressive MS) STUDIES:&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; color: rgb(255, 0, 0);"&gt;(7) ABBOTT M03-654&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;Placebo controlled trial studying the effects of ABT-874&lt;br /&gt;(Anti-IL-12 Antibody) looking for pt's 18 to 55 yrs old who have been off&lt;br /&gt;copaxone or interferons for at least 3 months&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; color: rgb(255, 0, 0);"&gt;(8) BAYHILL BHT-3009-01 &lt;/span&gt;&lt;br /&gt;&lt;br /&gt;Placebo controlled trial studying the effects of an&lt;br /&gt;Antigen-specific DNA vaccination given in combination with Lipitor or given&lt;br /&gt;alone, looking for pt's &gt;18yrs old who have been off interferons for at&lt;br /&gt;least 1 month&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; color: rgb(255, 0, 0);"&gt;(9) ACHIEVE GA/9013&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;This is a trial studying copaxone vs. betaseron 250 or&lt;br /&gt;rebif 44 looking for pt's 18 to 50 yrs old who HAVE been on betaseron or&lt;br /&gt;rebif for at least one year&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; color: rgb(255, 0, 0);"&gt;(10) ACORDA MS-F203 &lt;/span&gt;&lt;br /&gt;&lt;br /&gt;Placebo controlled trial studying the effects of&lt;br /&gt;fampirdine on fatigue and endurance looking for pt's 18 to 70 yrs old who&lt;br /&gt;can walk 25 feet with or without assistance&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; color: rgb(255, 0, 0);"&gt;(11) DAC-1012&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;Placebo controlled trial studying a new compound called&lt;br /&gt;Daclizumab looking for pt's 18 to 65 yrs old with at least 1 relapse in last&lt;br /&gt;9 months and on an interferon beta&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; color: rgb(51, 102, 255);"&gt;PPMS (primary progressive MS) ONLY:&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; color: rgb(255, 0, 0);"&gt;(12) OLYMPUS U2786g &lt;/span&gt;&lt;br /&gt;&lt;br /&gt;Placebo controlled trial studying the effects of&lt;br /&gt;Rituximab looking for pt's 18 to 65 yrs old who have positive band or&lt;br /&gt;elevated index in their CSF in last 2 years&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; color: rgb(51, 51, 255);"&gt;BLOOD DRAW ONLY TRIALS:&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; color: rgb(255, 0, 0);"&gt;(13) BAYHILL BHT3009-02&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;Blood marker trial looking for any male or female&lt;br /&gt;that have been newly diagnosed with MS and are off all therapies&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; color: rgb(255, 0, 0);"&gt;(14) T-GEN Gene Expression Trial &lt;/span&gt;&lt;br /&gt;&lt;br /&gt;To identify a surrogate genetic marker to&lt;br /&gt;be used in diagnostic testing and likely response to treatment&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Barrow Neurological Institute will have many other actively enrolling trials starting up within the next 6 to 9 months.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; color: rgb(255, 102, 0);"&gt;TO ENROLL IN ANY OF THE 14 TRIALS ABOVE...PLEASE CALL BARROW NEUROLOGICAL INSTITUTE AT 602-406-7711&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;Leave a message with your contact information.&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Lou DiCave, Colleen Sweeney, Krya Perry&lt;/span&gt; or &lt;span style="font-weight: bold;"&gt;Carrie Jones&lt;/span&gt; will call you with information on the trials currently being conducted and help you enroll if you qualify.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/11762243-111243317840299485?l=ms-treatments-research.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/11762243/posts/default/111243317840299485'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/11762243/posts/default/111243317840299485'/><link rel='alternate' type='text/html' href='http://ms-treatments-research.blogspot.com/2005/07/call-barrow-neurological-institute-at.html' title='CALL BARROW NEUROLOGICAL INSTITUTE AT 602-406-7711 TO ENROLL IN ANY OF THE 14 TRIALS BELOW'/><author><name>MSnewsChanel.com.com</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry></feed>
